GLP-1 receptor agonists may reduce risk of subarachnoid haemorrhage in type 2 diabetes patients Two large studies showed lower incidence of brain aneurysm rupture with GLP-1RA use GLP-1RAs improve vascular health by reducing inflammation and regulating cardiovascular risks
